Emergent BioSolutions (EBS) EV to FCF (2010 - 2026)
Emergent BioSolutions (EBS) posted EV to FCF of 5.35 for Q2 2026, up 172.17% on a QoQ basis from 7.42 in Q1 2026, and up 673.55% year-over-year from 0.69 in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) EV to FCF (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported EV to FCF for 17 years, with the latest figure at 5.35 in Q2 2026.
- On a quarterly basis, EV to FCF rose 673.55% year-over-year to 5.35 in Q2 2026; TTM through Jun 2026 was 3.36, a 628.25% increase from a year earlier, with the FY2025 full-year figure at 2.77, down 75.99% from the prior year.
- EV to FCF was 5.35 for Q2 2026 at Emergent BioSolutions, up from 7.42 in the prior quarter.
- The five-year high for EV to FCF was 6.75 in Q2 2024, with the low at 37.83 in Q3 2025.
- Average EV to FCF over 5 years is 5.02, with a median of 0.64 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: EV to FCF plunged 1994.33% in 2025, then soared 673.55% in 2026.
- Over 5 years, EV to FCF stood at 0.55 in 2022, then surged by 219.56% to 0.66 in 2023, then plunged by 872.44% to 5.07 in 2024, then soared by 216.28% to 5.89 in 2025, then fell by 9.17% to 5.35 in 2026.
- The last three EV to FCF figures came in at 5.35 (Q2 2026), 7.42 (Q1 2026), and 5.89 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.35 |
| Mar 31, 2026 | -7.42 |
| Dec 31, 2025 | 5.89 |
| Sep 30, 2025 | -37.83 |
| Jun 30, 2025 | 0.69 |
| Mar 31, 2025 | -7.57 |
| Dec 31, 2024 | -5.07 |
| Sep 30, 2024 | 2.00 |
| Jun 30, 2024 | 6.75 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | 0.66 |
| Sep 30, 2023 | 1.86 |
| Jun 30, 2023 | -2.30 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -3.18 |
| Jun 30, 2022 | -24.96 |
| Mar 31, 2022 | -23.50 |
| Dec 31, 2021 | 5.86 |
| Sep 30, 2021 | -59.34 |
API Access
Emergent BioSolutions EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();